{"schema_version":"secwatch.filing_event.v1","accession":"0001645113-22-000037","form_type":"8-K","ticker":"NVCR","cik":"0001645113","company_name":"NovoCure Ltd","filed_at":"2022-04-13T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.613403+00:00","generated_at":"2026-06-26T07:41:07.152983+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"NovoCure director Sherilyn McCoy not standing for reelection at June 2022 annual meeting","bullets":["Director Sherilyn McCoy informed NovoCure she will not stand for reelection at the June 8, 2022 annual meeting.","Decision is not due to any disagreement with the company; she cites a desire to focus on other professional commitments.","McCoy will continue to serve on the board until the expiration of her term at the annual meeting.","NovoCure thanked McCoy for her service and significant contributions."],"urls":{"canonical":"https://secwatch.observer/filing/0001645113-22-000037","json":"https://secwatch.observer/filing/0001645113-22-000037.json","markdown":"https://secwatch.observer/filing/0001645113-22-000037.md","text":"https://secwatch.observer/filing/0001645113-22-000037.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000037/0001645113-22-000037-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000037/nvcr-20220411.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T07:41:07.152983+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4a05d55bcd","claim":"Sherilyn McCoy departed as Director at NovoCure Ltd.","evidence_excerpt":"On April 11, 2022, Sherilyn McCoy, a Director of NovoCure Limited (the \"Company\") since 2018, notified the Company of her intention not to stand for reelection to the Board of Directors of the Company (the \"Board\") at the Company's 2022 annual general meeting of shareholders (the \"Annual Meeting\"), which is currently scheduled for June 8, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000037/0001645113-22-000037-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"not stand for reelection"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}